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● Correlation between hypothermia and death in review of SARS-CoV-2 cases  
● Probability of death was 2.06 times higher for those with hypothermia 
● Hypothermia useful as predictor of mortality in SARS-CoV-2 




















We observed patients to have variable temperatures.  The objective of the study was to 
identify if hypothermia in a patient infected with SARS-CoV-2 is associated with a higher than 
expected mortality.  
Methods: 
We reviewed 331 charts from patients hospitalized with SARS-CoV-2 between March 9 
to April 20, 2020.   
Results: 
The probability of death was 2.06 times higher for those with hypothermia than those 
without [95% C.I. (1.25, 3.38)]. In ventilated patients, there were 32 deaths. Of those, 75% had 
been hypothermic. In a prior review of 10,000 non-SARS-CoV-2 patients with sepsis, the 
mortality rate in patients with hypothermia was 47%.  Reviewed studies demonstrated a range of 
expected mortality rates in patients with ventilator dependent respiratory failure and sepsis.  In 
comparison, our study shows that within a group of critically ill patients with SARS-CoV-2 and 
hypothermia, the mortality rate exceeded those rates.  
Conclusion: 
Our review showed a significant association between hypothermia and death (p=0.0033).   
Predictors of mortality in SARS-CoV-2 disease can expedite earlier aggressive care. 
Additionally, in areas with limited resources or overburdened healthcare systems, there may be a 
need for resource allocation management and information about mortality risk may be helpful. 
 












In the current SARS-CoV-2 pandemic, it has been important to identify features in the 
clinical presentation that would serve as indicators of disease progression. There were 21,813,451 
diagnosed cases of SARS-CoV-2 throughout the world as of August, 16, 2020 with 5,564,376 of 
those cases in the United States. As of April 26, 2021, there are 148,442,514 million cases with 
the numbers continuing to rise (COVID-19 Coronavirus Pandemic 2020).  There have been times 
throughout the pandemic where we have been faced with limited resources specific to Remdisivir 
and Convalescent plasma, treatment options which have shown potential to be beneficial (Grein 
et. al, 2020, Joyner et.al, 2020). Studies are ongoing to verify the efficacy of these interventions.  
As providers we worried about the possibility of having to scale patients in order to determine who 
could receive those treatments. This concern did not manifest as a reality in our center, but it came 
close. However, we surmise that in resource poor areas, or in the event of a large surge of patients, 
this could become a necessity.   Fever has been identified as one of the hallmark presenting 
symptoms used as a marker for whom to screen for this infection. However in patients with this 
infection, temperature readings vary.  During the course of our clinical care of patients with SARS-
CoV-2 we identified patients with hypothermia, normothermia and hyperthermia. The number of 
patients with hypothermia seemed to exceed the number typically seen during the course of our 
clinical care of patients with infection and sepsis. Our study sought to further investigate this 
observation. 
Hypothermia is sometimes utilized as a therapeutic effort in sustaining the life of a person 
who presents with cardiac arrest. Likewise, hypothermia can be induced in trauma patients in an 










decrease in metabolic rate which can be protective against ischemia (Sailhamer 2007). 
Accidental hypothermia is an unintentional decrease in temperature in a person who does not 
have obvious intrinsic thermoregulatory dysfunction. This form of hypothermia may be as a 
result of excessive cold exposure (Hildebrand 2014). Hypothermia as it relates to our review is 
that which can be seen in sepsis and is felt to a consequence of impaired thermoregulation. The 
etiology of this is described as a “failure of the hypothalamus to regulate the core body 
temperature” (Faulds 2013).  There may be an alteration in the baseline temperature setpoint by 
the hypothalamus as a result of sepsis or severe infection. Alternatively it may be a nonspecific 
response due to widespread systemic inflammation (Leon 2004). 
Sepsis is the body’s harmful systemic reaction to microbial infection.  Hypothermia has 
been clearly associated with sepsis.  ICU and hospital mortality have been identified as being 
higher in septic patients with hypothermia (Wiewal 2016).  Fever or hypothermia can be 
symptoms identified in any degree of sepsis.  In 2017 a meta-analysis of studies was performed 
looking at temperature and mortality rates in patients with sepsis. Approximately 10,000 cases of 
sepsis were reviewed.  The reviewers found that septic patients with fever had an estimated 
mortality rate of approximately 22%.  The estimated mortality rate in patients with normal 
temperature was 31% and  the highest estimated mortality rate of  47% was found in 
hypothermic patients (Rumbus, 2017). 
Admission to the ICU for SARS-CoV-2 patients is associated with a high mortality rate, 
ranging from 16 to 78%, with an Italian review of 3,988 patients showing a mortality rate of 
close to 50% (Grasselli 2020). Understanding that ICU patients at a baseline have a high 










We expect to see a higher mortality rate in SARS-CoV-2 patients with hypothermia.  We 
are interested in how significant this association is and if there are any significant correlations 
with age, weight, oxygen requirement or inflammatory markers.  
 
Review of literature 
In 1868, Carl Reinhold Wunderlich measured body temperature in about 25,000 people 
and established a normal temperature as 98.6 ℉ and an elevated body temperature as 100.4 ℉ 
(Mackowiak 1998). 
Hypothermia is defined as a core temperature <35 ℃ (95 ℉) and is further classified as 
follows: mild 35 ℃ to 32 ℃, moderate 32 ℃ to 28 ℃, severe 28 ℃ to 20 ℃, and profound <20 
℃ (Fagenholz 2013).  Body temperature is closely regulated through a balance between heat 
production and heat dissipation. The pre-optic nucleus of the anterior hypothalamus is the 
thermal control center. In response to a decrease in core body temperature, the hypothalamus 
initiates mechanisms to conserve heat including shivering, and non shivering thermogenesis 
(increased activity of thyroxine and catecholamines). However, as the core temperature 
decreases below 35°C (95°F), the coordinated systems responsible for thermoregulation begin to 
fail (Kobeissi 2014). Proinflammatory cytokines including interleukin-6, interleukin-1 and TNF-
alpha play a crucial role in the genesis of a fever. However, there appears to be no correlation 
between decreased circulation of these cytokines and hypothermia (Marik 2000, Wiewel 2016). 
The mechanism of hypothermia in sepsis is unclear, however, many studies agree that 
hypothermic patients with septic shock have a significantly higher mortality rate and higher 










 Early case reports pointed out fever as a common presenting symptom for SARS-CoV-2 
infection, as commonly seen with other viral infections. In a meta-analysis of 3,062 patients with 
SARS-CoV-2, fever was noted in 80.4% of the patients (Zhu et al.,2000). Acute hypothermia has 
been described in a SARS-CoV-2 as a case report (Allard 2020). 
 
Methods 
We retrospectively reviewed the medical records of 331 patients who had been hospitalized 
at Broward Health Medical System hospitals.  We looked at the clinical outcomes of these adult 
patients with laboratory confirmed SARS-CoV-2 infection. The patients were hospitalized and 
treated for SARS-CoV-2 infection between March 31, 2020 to April 20, 2020. Our Institutional 
Review Board granted full waiver for this retrospective chart review research project.  Data points 
we reviewed were temperature, age, oxygen requirements, inflammatory markers, weight, 
underlying medical conditions and outcomes.  Five physicians reviewed the medical records. We 
documented the age, body mass index (BMI), oxygen requirement, measures of C reactive protein, 
D dimer, Ferritin and their outcome (discharge, discharge with oxygen, death). Statistical analysis 
















Statistical Analysis and Results  
 
Analysis 1: Hypothermic Status: Outcomes 
 
These data contained only hypothermia patients, and so a regression to determine the effect of 
hypothermia on the odds of death, relative to other patient-specific variables, could not be 
performed.  However, a frequency analysis was performed using the categories of Hypothermia 
(versus not) and Death (versus not) as outlined in the Summary tab of the file.  In all cases, a 
significance level of 0.05 was used. 
 
A Fisher’s Exact Test was performed on the above frequency table, indicating that there is a 
significant association between Hypothermia and Death (p=0.0033).  In particular, the 
probability of death was 2.06 times higher for those with Hypothermia than those without [95% 
C.I.  (1.25, 3.38)]. 
Analysis 2:  Hypothermic Status of Deceased Patients:  Steroid Administration 
Although Regression is preferable when dealing with multiple possibly-related independent 
variables, the count statistics associated with individual categorical variables can be useful.  In 
all cases, p-values represent the outcome of either a Chi-squared or Fisher’s Exact test, as 
appropriate.  
The following analysis was performed checking for variable interactions within the regression 
and contingency tables, analyzing differences between deceased patients who were hypothermic 










There was also no statistically significant association between hypothermia status and steroid 
administration (Table 3): 
Analysis 3: Hypothermic Status of Deceased Patients:  Multinomial Logistic Regression 
An exhaustive search of all linear and interactive models yielded no statistically significant 
predictors of hypothermia in deceased patients, among all variables considered above. 
There were no statistically significant relationships found between elevated c-reactive protein 
(CRP) at a level of greater than 1.0 ug.dl, elevated ferritin at a level of >275 ng/ml, elevated 
body mass index (BMI) greater than or equal to 30 with respect to category and discharge status 
for the hypothermic patients in this study.  
  
Discussions/Conclusions 
The proposed pathophysiological mechanism of sepsis in SARS-CoV-2 associated 
infections is complex and typically involves patients with severe disease. A cytokine response 
syndrome has been identified as the precursor to shock in cases of severe disease, however, the 
virological mechanism remains unidentified for the time being. Inference of the exact process 
has been drawn from similarities in severe disease seen with influenza which involves the release 
of cytokines in lung epithelial cells.  Elevated temperatures can augment aspects of humoral and 
cellular immunity (Launey et al., 2011). However, a percentage of septic patients present with 
hypothermia rather than hyperthermia.  Similar to hyperthermia, studies have shown that 
hypothermia is associated with an increased risk of mortality in sepsis (Young et al., 2012).  In 










describe acute hypothermia in a patient with SARS-Cov2 infection and this is something we saw 
in 34% of the cases we reviewed.   
 The Recovery Trial (2020) showed a  reduction in 28 day mortality among those who 
received glucocorticoid class drug, dexamethasone. This study was published after the date of 
most patients whose charts we reviewed. However, we still found that patients had received 
hydrocortisone or solumedrol, more often later in the course of their hospitalization.  It is known 
that the use of glucocorticoids affects body temperature and can result in hypothermia (Kaimuma 
2009). We therefore took into consideration the effect of steroid use in patients in our review 
who had expired.  Of the 39 Hypothermic patients who died, 21 (53.8%) received steroids and 18 
(46.1%) did not. Of the 24 Non-Hypothermic patients who died, 9 (37.5%) received steroids and 
15 (62.5%) did not. Statistical analysis did not reveal any statistically significant association 
between hypothermia and steroid administration. 
A review of 624 patients diagnosed with severe sepsis showed that patients with 
hypothermia as defined by a temperature of less than 36.5℃ on presentation had worse 
sequential organ failure assessment scores compared to those with a temperature above 36.5℃. 
The 28 day and in hospital mortality was found to be higher in the group with hypothermia 
(Kushimoto et al., 2013). In reviewing our results, looking at the category of ventilated patients, 
there were 32 deaths (Table 1). Of those deaths, 75% of the patients had been hypothermic. In a 
prior review of 10,000 non-SARS-CoV-2 patients with sepsis, the mortality rate in patients with 
hypothermia was 47%.  Reviewed studies demonstrated a range of expected mortality rates in 
patients with ventilator dependent respiratory failure and sepsis (Rumbus 2017).  In comparison, 
our study shows that within a group of critically ill patients with SARS-CoV-2 and hypothermia, 










and sepsis patients from historical data can be made as the SARS-CoV-2 patients met some or all 
criteria for the diagnosis of sepsis, particularly when in the intensive care unit.  While we 
understand that the mere presence of hypothermia indicates that a patient is severely ill, the 
findings that there is a statistically significant association between hypothermia and death in the 
SARS-CoV-2 population can be used as an indicator of poor outcome. Throughout the 
pandemic, we have been faced with limited resources such as the antiviral Remdisivir, or 
convalescent plasma. Having a better understanding of potential patient outcomes, this 
information can be utilized to assist in resource management.  
Our review identified a significant association between hypothermia and death 
(p=0.0033). In particular, the probability of death was 2.06 times higher for those with 
hypothermia than those without [95% C.I. (1.25, 3.38)]. Older, heavier patients or with one or 
more underlying medical conditions (data not shown) were no more prevalent among 
hypothermic patients who died.  In our review we identified that among the hypothermic 
patients, the percentage of patient death increased as the D-dimer category level increased.  
Although these associations were statistically significant, causality cannot be inferred.  Previous 
reports have noted this, and autopsy correlation has been documented.  A comprehensive 
literature review performed by Sakka, et al. (2020) identified elevated D-dimer levels 
significantly associated with the risk of mortality. Thrombosis of small and mid sized arteries 
were seen in a pathology case series from autopsies on 11 patients who had died from SARS-
CoV-2 infection (Lax, et al. 2020).  Our study demonstrates what has been detailed by Yao, et 
al., that D-Dimer does serve as a biomarker for disease severity.  
The National Institute of Health treatment guidelines include a report indicating possible 










therefore reviewed our data looking to see if there was any correlation in the patients between 
receipt of convalescent plasma and hypothermia.  We did not find any causal relationship. 
We would recommend that patients with hypothermia be recognized as being at 
higher risk for poor outcome, particularly if intubated.  Our report describes our single 
institutions experience and might not be generalized to other institutions or locations. Additional 
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Table 1: Parameters Reviewed from Charts of SARS-CoV-2 Patients 
Temperature Hypothermia < or 
= 96.5℉ 
Hyperthermia > or = 100.4 ℉  
Oxygen requirements Room Air Oxygen Supplementation Ventilator 
D Dimer  <0.5 ug/ml 0.5-3.0 >3.0 
Ferritin <275 ng/ml > or = 275  
C Reactive Protein >1.0 mg/dl   
Weight BMI 18-29 BMI > or = 30  




















Table 2: Hypothermic Status and Outcomes 
 Dead Alive % Dead 
Hypothermic 
patients 39 96 28.9% 
Not hypothermic 
        patients  43 218 16.5% 

























Table 3. Steroid Administration 
 Yes No 
Hypothermic patient 21 (70.0%) 18 (54.5% 
Non-Hypothermic patient 9 15 
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